Amaro, Rosanel
Li Bassi, Gianluigi
Motos, Ana
Fernandez-Barat, Laia http://orcid.org/0000-0001-7528-9636
Aguilera Xiol, Eli
Rigol, Montserrat
Frigola, Gerard http://orcid.org/0000-0001-6794-6456
Travierso, Chiara
Bobi, Joaquim
Pagliara, Francesco
Carbonara, Marco
Comaru, Talitha http://orcid.org/0000-0002-3574-6318
Chiurazzi, Chiara
Yang, Minlan
Yang, Hua
Arrieta, Marta
Marti, Joan Daniel
De Rosa, Francesca
Saco, Maria Adela
Rinaudo, Mariano
Terraneo, Silvia
Schultz, Marcus J.
Nicolau, David P.
Artigas, Antonio
Ramirez, Jose
Torres, Antoni http://orcid.org/0000-0002-8643-2167
Article History
Received: 16 September 2020
Accepted: 16 September 2021
First Online: 21 October 2021
Competing interests
: A.T. has received grants from MedImmune, Cubist, Bayer, Theravance and Polyphor and personal fees as an advisory board member from Bayer, Roche, The Medicines CO and Curetis. He has received personal fees as a member of the speaker’s bureau from GSK, Pfizer, Astra Zeneca and Biotest Advisory Board, outside the submitted work. None of the other authors have any competing interests with the current publication.
Free to read: This content has been made available to all.